Transforming growth factor beta, which is highly expressed in leprosy patients (58), is able to maintain high IDO-1 expression in DCs through phosphorylation of its immune-based inhibitory tyrosine motifs, leading to a sustained immunoregulatory effect (62). Here, IDO1 is linked to leprosy.